by nobilistx | Jun 14, 2017 | Uncategorized |
Nobilis Therapeutics published the results of its pioneering clinical trial on 81 patients with Panic Disorder in the Journal of Translational Medicine. Patients were treated with NBTX-001 with remarkable results. This study validates the company’s methodology...
by nobilistx | Jun 13, 2017 | Uncategorized |
Nobilis Therapeutics has received a notice of allowance for its most important patent. The patent covers the uses of noble gas-based therapies in a variety of psychiatric illnesses. Please read our press release...